CD8⁺CD161^hi T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation

Affiliations

• ¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
• ² Peking University Institute of Hematology, Peking University People's Hospital, No 11 Xizhimen South Street, Beijing, 100044, China.
• ³ Department of Hematology, The First Affiliated Hospital of Xiamen University, 55 Zhenhai Road, Xiamen, 361003, Fujian, China.
• ⁴ Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
• ⁵ Peking-Tsinghua Center for Life Sciences, Beijing, 100044, China.
• ⁶ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhao.xiaosu@outlook.com.
• ⁷ Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China. zhao.xiaosu@outlook.com.
• ⁸ Collaborative Innovation Center of Hematology, Peking University, Beijing, China. zhao.xiaosu@outlook.com.
• ⁹ Peking University Institute of Hematology, Peking University People's Hospital, No 11 Xizhimen South Street, Beijing, 100044, China. zhao.xiaosu@outlook.com.